Sunday, May 9, 2010

Tevron Solutions Fully Support all Cerner Applications

Nashua, New Hampshire, May 6, 2010 – Tevron today announced the addition of support for all Cerner environments to its suite of APM & Testing solutions. Cerner is a global supplier of healthcare solutions. Working together with more than 8,000 clients worldwide, Cerner is solving healthcare's many challenges by making sure the right people have the right information at the right time. With the latest releases of CitraTest, CitraTest APM, and CitraTest VU, Tevron again istaking the lead role in the APM & testing industry in providing support for every Cerner application including Millennium, PowerWorks, LifeSciences, and more. As many medical groups, hospitals, pharmacies, and integrated healthcare organizations move towards Cerner, Tevron’s APM & testing solutions will continue to offer the industry lead for application monitoring, load testing, and general automation for those critical deployments.

To learn more about Tevron’s automated testing and monitoring solutions or to request additional information, please call +1.702.518.7435, email sales@tevron.com or visit www.tevron.com.

ABOUT TEVRON

Tevron® is a global leader in APM and Automated Testing. Through our all encompassing customer-centric vision and advanced technology, our APM & Testing Solutions allow the unique flexibility of supporting every application across the enterprise with one methodology delivering the ability to test, monitor, enforce SLAs, and optimize performance with confidence and ease. Founded in 2001, Tevron® is a global organization and is privately held. Our vast and diverse range of customers are global leaders and include companies such as Alcon Labs, Alverno, Northrop Grumman, Xerox, Hewlett Packard, Siemens, and Lucent Technologies, to name a few.

TRADEMARKS

Tevron, the Tevron logo, and CitraTest are registered trademarks of Tevron, LLC. Cerner is a registered trademark of Cerner. All other product references herein are either trademarks or registered trademarks of their respective owners.

No comments: